He doesn't actually know.
All you have to do is look at the first paragraph - "intended for use as a maintenance therapy after receiving..."
The patients that received the allogeneic therapy had already had a stem cell transplant (HSCT), which means they had already achieved a complete remission to be eligible for the study.
The compound is intended to prevent relapse; not to treat cancer.
@Eileendover you have yourself to blame, but that's where the best learnings take place. My thoughts: spend more time reading peer reviewed journals than HotCopper. Hopefully, your new venture works out for you! I think you have made the right choice investing in yourself.
Media Thread, page-15118
-
- There are more pages in this discussion • 528 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IMU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
4.8¢ |
Change
-0.002(4.00%) |
Mkt cap ! $356.9M | |||
| Open | High | Low | Value | Volume |
| 5.0¢ | 5.0¢ | 4.7¢ | $2.298M | 47.86M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 5 | 1925982 | 4.8¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 4.9¢ | 3452098 | 12 |
View Market Depth
| Last trade - 16.10pm 27/09/2024 (20 minute delay) ? |
| IMU (ASX) Chart |